Suzhou Basecare Medical Corporation Limited

Equities

2170

CNE100004BC1

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:09:13 2024-04-23 am EDT 5-day change 1st Jan Change
2 HKD +2.56% Intraday chart for Suzhou Basecare Medical Corporation Limited +2.04% -14.89%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Suzhou Basecare Medical Corporation Limited Announces Board Appointments CI
Suzhou Basecare Medical's Expects Gross Profit to Jump Up To 20.5% in First Half MT
Suzhou Basecare Medical Corporation Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
Suzhou Basecare Medical Corporation Limited Announces Executive Changes CI
Suzhou Basecare Completes $40 Million Acquisition of Singaporean Fertility Products Provider MT
Suzhou Basecare Medical Corporation Limited completed the acquisition of BMX Holdco Pte. Ltd. from individual investors and funds. CI
Suzhou Basecare Medical Corporation Limited Announces Resignation of Chau Kwok Keung Independent Non-Executive Director, Effect from June 14, 2023 CI
Suzhou Basecare Medical to Buy Entire Stake in Singapore-Based Fertility Products Provider MT
Suzhou Basecare Medical Corporation Limited entered into an agreement to acquire BMX Holdco Pte. Ltd. from individual investors and funds for approximately CNY 280 million. CI
Suzhou Basecare Medical Trims Loss in 2022 as Revenue Jumps 31% MT
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Over a dozen Chinese-based firms say they have minimal exposure to SVB RE
Suzhou Basecare Medical Eyes Shanghai IPO MT
Suzhou Basecare Medical Corporation Limited Announces Resignation of Zhang Jiecheng as Non-Executive Director CI
Suzhou Basecare Medical CFO Resigns MT
Suzhou Basecare Medical Corporation Limited Announces Executive Changes CI
Suzhou Basecare Medical Corporation Limited Announces Management Changes CI
Suzhou Basecare Medical H1 Loss Shrinks MT
Suzhou Basecare Medical Corporation Limited(SEHK:2170) dropped from S&P Global BMI Index CI
Suzhou Basecare Medical Corporation Limited Announces Executive Changes CI
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Dire performance of new Hong Kong listings clouds prospects for IPO pickup RE
Basecare Medical to Offload 35% Stake in Zhejiang Cellpro for $9.5 Million; Basecare Shares Slip 7% MT
Chart Suzhou Basecare Medical Corporation Limited
More charts
Suzhou Basecare Medical Co Ltd, formerly Jiangsu Double Helix Biology Science and Technology Co Ltd, is a China-based investment holding company mainly engaged in the provision of assisted reproductive genetic testing solutions. The Company provides genetic testing solutions and sells genetic testing equipment and instruments. The genetic testing solutions include sales of testing kits and provision of testing services. The Company's main products include PGT-A kits. The Company mainly conducts business within the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.849 CNY
Average target price
11.18 CNY
Spread / Average Target
+504.78%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2170 Stock
  4. News Suzhou Basecare Medical Corporation Limited
  5. Suzhou Basecare Signs Strategic Collaboration Framework Deal with Qingdao Haier Biomedical